Turn Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Chaudhary Zuraiz | See Remarks | Purchase | 2,500 | $3.50 | $8,750 | 12,500 | Dec 12, 2025 |
| GOLDEN ARTHUR F | — | Purchase | 9,868 | $3.44 | $33,946 | 60,602 | Nov 24, 2025 |
| GOLDEN ARTHUR F | — | Purchase | 20,532 | $2.87 | $58,927 | 50,734 | Nov 21, 2025 |
| Chaudhary Zuraiz | See Remarks | Purchase | 1,000 | $3.29 | $3,290 | 10,000 | Nov 20, 2025 |
| Chaudhary Zuraiz | See Remarks | Purchase | 2,500 | $3.62 | $9,050 | 7,550 | Nov 17, 2025 |
| Chesed Abraham | — | Purchase | 14,286 | $4.60 | $65,716 | 1,447,268 | Oct 23, 2025 |
| Chaudhary Zuraiz | See Remarks | Purchase | 5,050 | $4.95 | $24,998 | 5,050 | Oct 23, 2025 |
| GOLDEN ARTHUR F | — | Purchase | 20,202 | $4.95 | $100,000 | 30,202 | Oct 23, 2025 |
| Ghodadra Neilesh Shailesh | Chief Medical Officer | Award / Grant | 10,000 | — | — | 10,000 | Oct 8, 2025 |
| Kester Kent Edward | — | Award / Grant | 10,000 | — | — | 10,000 | Oct 8, 2025 |
| GOLDEN ARTHUR F | — | Award / Grant | 10,000 | — | — | 10,000 | Oct 8, 2025 |
| Gengos Andrew | — | Award / Grant | 10,000 | — | — | 10,000 | Oct 8, 2025 |